You just read:

New LEADER Analysis Shows Victoza® Reduces Cardiovascular Risk in People With Type 2 Diabetes Regardless of Severe Hypoglycaemia Events

News provided by

Novo Nordisk

13 Jun, 2017, 02:30 BST